Hard to Treat Diseases Inc. Targets an EU Based Stem Cell …
Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica Bio Chem, announces that it is targeting an EU based company, and has initiated talks that may involve a merger. Hard to Treat Diseases Inc. (HTDS) and …
[Read the full article here]Related News:
HTDS announces possible merger with EU-based, stem-cell research company
Hard To Treat Diseases (HTDS) Exploration Of A 25 Billion Dollar Industry Regenerative Medicine and Stem Cell Bank …
Hard to Treat Diseases Inc. Stem Cell Developments